Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia
· Delayed Price · Currency is AUD 2.290
+0.210 (10.10%)
Apr 24, 2025, 3:40 PM AEST
Clarity Pharmaceuticals Revenue
Clarity Pharmaceuticals had revenue of 4.69M AUD in the half year ending December 31, 2024, a decrease of -18.22%. This brings the company's revenue in the last twelve months to 10.78M, up 13.61% year-over-year. In the fiscal year ending June 30, 2024, Clarity Pharmaceuticals had annual revenue of 11.51M with 17.41% growth.
Revenue (ttm)
10.78M
Revenue Growth
+13.61%
P/S Ratio
62.02
Revenue / Employee
215.54K
Employees
50
Market Cap
668.41M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 17.12B |
| Ansell | 3.00B |
| Mesoblast | 9.16M |
Clarity Pharmaceuticals News
- 5 months ago - Indoco Remedies stock surges 8% on partnership with Clarity Pharma in the UK - Business Upturn
- 5 months ago - Indoco Remedies partners with Clarity Pharma to strengthen UK presence - Business Upturn
- 6 months ago - Rising Shares at Clarity Pharmaceuticals as it Launches Second Phase III Trial and Promotes Michelle Parker to CEO - CEOWORLD magazine
- 9 months ago - Three ASX companies jockeying to be the next biotech winners - The Australian Financial Review